Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)
9 Months Ended
Sep. 30, 2023
Net Loss per Share [Abstract]  
Schedule of Diluted Net Loss Per Share The following securities were excluded from the computation of diluted net loss per share for the periods presented because including them would have been anti-dilutive:
    For the three and nine
months ended
    September 30,  
    2023     2022  
Stock options     100,000       118,388  
Warrants     672,462       1,567,720  
Restricted stock units     2,496,587       2,412,759  
Total common stock equivalents     3,269,049       4,098,867